We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPL
851
DELISTED
Buckeye Partners, L.P.
BPL
$7.51M 0.02%
117,531
+419
+0.4% +$27.5K
FTCS icon
852
First Trust Capital Strength ETF
FTCS
$7.92B
$7.51M 0.02%
164,837
-43,786
-21% -$1.98M
ZD icon
853
Ziff Davis
ZD
$2.04B
$7.51M 0.02%
101,465
-24,066
-19% -$1.8M
REG icon
854
Regency Centers
REG
$14.5B
$7.5M 0.02%
119,671
-8,989
-7% -$568K
JWN
855
DELISTED
Nordstrom
JWN
$7.46M 0.02%
156,066
+8,726
+6% +$397K
USA icon
856
Liberty All-Star Equity Fund
USA
$1.83B
$7.46M 0.02%
1,317,283
-263,591
-17% -$1.46M
ABB
857
DELISTED
ABB Ltd
ABB
$7.44M 0.02%
298,680
-173,511
-37% -$4.26M
CS
858
DELISTED
Credit Suisse Group
CS
$7.43M 0.02%
509,208
+48,863
+11% +$705K
DINO icon
859
HF Sinclair
DINO
$15.7B
$7.42M 0.02%
270,071
+763
+0.3% +$20.4K
CZA icon
860
Invesco Zacks Mid-Cap ETF
CZA
$192M
$7.41M 0.02%
122,823
+27,745
+29% +$1.64M
WPC icon
861
W.P. Carey
WPC
$16.5B
$7.39M 0.02%
114,319
+10,687
+10% +$676K
ICUI icon
862
ICU Medical
ICUI
$4.3B
$7.37M 0.02%
42,711
+836
+2% +$134K
FPX icon
863
First Trust US Equity Opportunities ETF
FPX
$1.54B
$7.36M 0.02%
123,234
+20,999
+21% +$1.24M
IDXX icon
864
Idexx Laboratories
IDXX
$46.4B
$7.35M 0.02%
45,544
+7,139
+19% +$1.16M
HACK icon
865
Amplify Cybersecurity ETF
HACK
$2.87B
$7.33M 0.02%
244,324
+53,639
+28% +$1.6M
XME icon
866
State Street SPDR S&P Metals & Mining ETF
XME
$4.12B
$7.33M 0.02%
244,624
-80,309
-25% -$2.37M
FNSR
867
DELISTED
Finisar Corp
FNSR
$7.31M 0.02%
281,313
+146,627
+109% +$3.65M
WDAY icon
868
Workday
WDAY
$42.3B
$7.3M 0.02%
75,251
+4,269
+6% +$399K
CPRT icon
869
Copart
CPRT
$27.2B
$7.27M 0.02%
915,004
-193,564
-17% -$1.48M
VR
870
DELISTED
Validus Hold Ltd
VR
$7.26M 0.02%
139,735
+8,891
+7% +$479K
GBCI icon
871
Glacier Bancorp
GBCI
$6.63B
$7.26M 0.02%
198,233
+19,650
+11% +$672K
RENX
872
DELISTED
RELX N.V.
RENX
$7.26M 0.02%
350,935
+7,926
+2% +$158K
ODFL icon
873
Old Dominion Freight Line
ODFL
$45.6B
$7.25M 0.02%
228,270
+16,557
+8% +$487K
VAR
874
DELISTED
Varian Medical Systems, Inc.
VAR
$7.17M 0.02%
69,502
+20,698
+42% +$1.99M
RSPP
875
DELISTED
RSP Permian, Inc.
RSPP
$7.16M 0.02%
221,987
+17,104
+8% +$635K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.